Retrospective data analysis of newly diagnosed Crohn's disease patients in gastroenterological surgeries
- Conditions
- MedDRA - 10011401: Crohn's DiseaseK50Crohn disease [regional enteritis]
- Registration Number
- DRKS00000076
- Lead Sponsor
- FERRING Arzneimittel GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 166
Inclusion Criteria
Patients with confirmed diagnosis of Crohn's disease
- Inital diagnosis after 01.01.2000
- initial treatment of first flare with mesalazine
- at least 12 months follow-up
- written informed consent
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of prognostic parameters correlation with the response to mesalazine in the first flare of Crohn's disease and during the following maintenance therapy.<br>Documentation of historic medical data in questionnaires
- Secondary Outcome Measures
Name Time Method